The Norwegian Immunotherapy in Multiple Myeloma Study | stella

Learn About Find trials matched to me

About Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Norwegian Immunotherapy in Multiple Myeloma Study | stella

Back to Myeloma Multiple trials

Recruiting

Trial locations(23 sites)

Norway

Sørlandet Hospital - Arendal, Arendal

Ålesund hospital, Department of hematology, Ålesund

Haukeland University Hospital, Bergen

Bodø Hospital, Bodø

Bærum Hospital, Bærum

Key details

Sponsor

St. Olavs Hospital

Collaborators

Norwegian University of Science and Technology, Haukeland University Hospital

Enrollment target

~400 participants

Started

January 2025

Primary completion

January 2029

Age range

18 Years and older

Last updated on clinicaltrials.gov in March 2025.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Tobias S Slørdahl, MD PhD

St. Olavs Hospital

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.